The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
A review on coronary artery disease, its risk factors, and therapeutics
Abstract
Coronary artery disease (CAD) is one of the major cardiovascular diseases affecting the global human population. This disease has been proved to be the major cause of death in both the developed and developing countries. Lifestyle, environmental factors, and genetic factors pose as risk factors for the development of cardiovascular disease. The prevalence of risk factors among healthy individuals elucidates the probable occurrence of CAD in near future. Genome‐wide association studies have suggested the association of chromosome 9p21.3 in the premature onset of CAD. The risk factors of CAD include diabetes mellitus, hypertension, smoking, hyperlipidemia, obesity, homocystinuria, and psychosocial stress. The eradication and management of CAD has been established through extensive studies and trials. Antiplatelet agents, nitrates, β‐blockers, calcium antagonists, and ranolazine are some of the few therapeutic agents used for the relief of symptomatic angina associated with CAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Heart Disease and Stroke Statistics—2014 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2014) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,215
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
MACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253 · cited 1×
“…have been established by extensive epidemiological research and these are smoking (US Department of Health and Human Services, 1990), diabetes (Stamler, Vaccaro, Neaton, Wentworth, & Group MRFITR., 1993), hyperlipidemia (Verschuren et al., 1995), and hypertension (MacMahon et al., 1990; Figure 2).”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Abifadel, M., Varret, M., Rabès, J.-P., Allard, D., Ouguerram, K., Devillers, M., Cruaud, C., Benjannet, S., Wickham, L., Erlich, D., et al. (2003) · Nature Genetics · doi:10.1038/ng1161 · Cited by 2,985
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Global atlas on cardiovascular disease prevention and control.
Mendis, S., Puska, P., & Norrving, B. G. (2011) · Virtual Defense Library (Ministerio de Defensa) · Cited by 2,691
Rosengren, A., Hawken, S., Ôunpuu, S., Sliwa, K., Zubaid, M., Almahmeed, W. A., Blackett, K. N., Sitthi-amorn, C., Sato, H., & Yusuf, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17019-0 · Cited by 2,414
Genomewide Association Analysis of Coronary Artery Disease
Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H.-E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072366 · Cited by 2,044
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.
Ks, M. (1969) · PubMed Central · Cited by 1,803
WHO MONICA Project Principal Invest (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90084-4 · Cited by 1,794
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
Heritable Disorders of Connective Tissue
(1960) · Postgraduate Medical Journal · doi:10.1136/pgmj.36.415.346 · Cited by 1,527
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000048856.22331.50 · Cited by 1,420
One-year cardiovascular event rates in outpatients with atherothrombosis
Steg, P. G., Bhatt, D. L., Wilson, P. W. F., D’Agostino, R., Ohman, E. M., Röther, J., Liau, C.-S., Hirsch, A. T., Mas, J.-L., Ikeda, Y., et al. (2007) · JAMA · doi:10.1001/jama.297.11.1197 · Cited by 1,382
Stress and cardiovascular disease
Steptoe, A., & Kivimäki, M. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.45 · Cited by 1,321
The natural history of homocystinuria due to cystathionine beta-synthase deficiency.
Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B. M., Pyeritz, R. E., Andria, G., Boers, G. H. J., Bromberg, I. L., & Cerone, R. (1985) · PubMed · Cited by 1,256
Use of Unlinked Genetic Markers to Detect Population Stratification in Association Studies
Pritchard, J. K., & Rosenberg, N. A. (1999) · The American Journal of Human Genetics · doi:10.1086/302449 · Cited by 1,198
A Tale of Coronary Artery Disease and Myocardial Infarction
Nabel, E. G., & Braunwald, E. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112570 · Cited by 994
Ozaki, K., Ohnishi, Y., Iida, A., Sekine, A., Yamada, R., Tsunoda, T., Sato, H., Sato, H., Hori, M., Nakamura, Y., et al. (2002) · Nature Genetics · doi:10.1038/ng1047 · Cited by 952
Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease
Keys, A. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674497887 · Cited by 909
Towards the physiological function of uric acid
Becker, B. F. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90143-i · Cited by 833
Serruys, P. W., Kutryk, M. J. B., & Ong, A. T. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra051091 · Cited by 762
Parisi, A. F., Folland, E. D., & Hartigan, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260102 · Cited by 736
The cardiovascular toll of stress
Brotman, D. J., Golden, S. H., & Wittstein, I. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61305-1 · Cited by 713
Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699 · cited 1×
“…might have a role in transforming growth factor β (TGF‐β)‐induced growth inhibition, which is involved in the pathogenesis of CAD (Kalinina et al., 2004; Lowe & Sherr, 2003). pRb pathway is inhibited by p16INK4a and p15INK4b which are coded by CDKN2A and CDKN2B, respectively, whereas p14ARF coded…”
BackgroundThe Coronary Artery Disease (C4D) Genetics Consortium (2011) · Nature Genetics · doi:10.1038/ng.782 · Cited by 674
Simons, M., Annex, B. H., Laham, R. J., Kleiman, N., Henry, T., Dauerman, H., Udelson, J. E., Gervino, E. V., Pike, M., Whitehouse, M. J., et al. (2002) · Circulation · doi:10.1161/hc0802.104407 · Cited by 645
Garcia, C. K., Wilund, K., Arca, M., Zuliani, G., Fellin, R., Maioli, M., Calandra, S., Bertolini, S., Cossu, F., Grishin, N., et al. (2001) · Science · doi:10.1126/science.1060458 · Cited by 624
Pasmant, E., Laurendeau, I., Héron, D., Vidaud, M., Vidaud, D., & Bièche, I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2004 · Cited by 618
9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response
Harismendy, O., Notani, D., Song, X., Rahim, N. G., Tanasa, B., Heintzman, N., Ren, B., Fu, X.-D., Topol, E. J., Rosenfeld, M. G., et al. (2011) · Nature · doi:10.1038/nature09753 · Cited by 611
Verschuren, W. M. M. (1995) · JAMA · doi:10.1001/jama.1995.03530020049031 · Cited by 573
THE LDL RECEPTOR LOCUS IN FAMILIAL HYPERCHOLESTEROLEMIA: Mutational Analysis of a Membrane Protein
Hobbs, H. H., Russell, D. W., Brown, M. S., & Goldstein, J. L. (1990) · Annual Review of Genetics · doi:10.1146/annurev.ge.24.120190.001025 · Cited by 553
Reilly, M. P., Li, M., He, J., Ferguson, J. F., Stylianou, I. M., Mehta, N. N., Burnett, M. S., Devaney, J. M., Knouff, C. W., Thompson, J. R., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61996-4 · Cited by 536
JUULMOLLER, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92619-q · Cited by 517
Broadbent, H. M., Peden, J. F., Lorkowski, S., Goel, A., Ongen, H., Green, F., Clarke, R., Collins, R., Franzosi, M. G., Tognoni, G., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm352 · Cited by 506
Fibroblast Growth Factors as Multifunctional Signaling Factors
Szebenyi, G., & Fallon, J. F. (1998) · International Review of Cytology · doi:10.1016/s0074-7696(08)60149-7 · Cited by 484
Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein
Bogdanov, V. Y., Balasubramanian, V., Hathcock, J., Vele, O., Lieb, M., & Nemerson, Y. (2003) · Nature Medicine · doi:10.1038/nm841 · Cited by 467
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C., Salen, G., Shefer, S., Batta, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215387 · Cited by 457
Assmann, G., & Schulte, H. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90220-7 · Cited by 449
Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease
Badimon, L., Padró, T., & Vilahur, G. (2012) · European Heart Journal: Acute Cardiovascular Care · doi:10.1177/2048872612441582 · Cited by 430
Signal transduction by fibroblast growth factor receptors
Klint, P. (1999) · Frontiers in Bioscience · doi:10.2741/klint · Cited by 424
Laham, R. J., Sellke, F. W., Edelman, E. R., Pearlman, J. D., Ware, J. A., Brown, D. L., Gold, J. P., & Simons, M. (1999) · Circulation · doi:10.1161/01.cir.100.18.1865 · Cited by 409
The response‐to‐retention hypothesis of atherogenesis reinforced
Williams, K. J., & Tabas, I. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00012 · Cited by 395
The epidemiology of cardiovascular disease in the UK 2014
Bhatnagar, P., Wickramasinghe, K., Williams, J., Rayner, M., & Townsend, N. (2015) · Heart · doi:10.1136/heartjnl-2015-307516 · Cited by 390
Lazarous, D. F., Shou, M., Scheinowitz, M., Hodge, E., Thirumurti, V., Kitsiou, A. N., Stiber, J. A., Lobo, A. D., Hunsberger, S., Guetta, E., et al. (1996) · Circulation · doi:10.1161/01.cir.94.5.1074 · Cited by 386
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression
Cunnington, M. S., Santibanez Koref, M., Mayosi, B. M., Burn, J., & Keavney, B. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000899 · Cited by 379
Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification: A Cohort Study
Kavousi, M., Elias-Smale, S., Rutten, J. H. W., Leening, M. J. G., Vliegenthart, R., Verwoert, G. C., Krestin, G. P., Oudkerk, M., de Maat, M. P. M., Leebeek, F. W. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-6-201203200-00006 · Cited by 360
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)
Pajukanta, P., Lilja, H. E., Sinsheimer, J. S., Cantor, R. M., Lusis, A. J., Gentile, M., Duan, X. J., Soro-Paavonen, A., Naukkarinen, J., Saarela, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1320 · Cited by 347
Chronic Coronary Artery Disease: Diagnosis and Management
Cassar, A., Holmes, D. R., Rihal, C. S., & Gersh, B. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0391 · Cited by 324
Laakso, M., Lehto, S., Penttilä, I., & Pyörälä, K. (1993) · Circulation · doi:10.1161/01.cir.88.4.1421 · Cited by 301
Coronary Heart Disease among Minnesota Business and Professional Men Followed Fifteen Years
KEYS, A., TAYLOR, H. L., BLACKBURN, H., BROZEK, J., ANDERSON, J. T., & SIMONSON, E. (1963) · Circulation · doi:10.1161/01.cir.28.3.381 · Cited by 296
Genetic--epidemiologic study of early-onset ischemic heart disease.
Nora, J. J., Lortscher, R. H., Spangler, R. D., Nora, A. H., & Kimberling, W. J. (1980) · Circulation · doi:10.1161/01.cir.61.3.503 · Cited by 294
Zhao, G., Huang, L., Song, M., & Song, Y. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.023 · Cited by 282
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
Krimpenfort, P., IJpenberg, A., Song, J.-Y., van der Valk, M., Nawijn, M., Zevenhoven, J., & Berns, A. (2007) · Nature · doi:10.1038/nature06084 · Cited by 269
Homocyst(e)ine and arterial occlusive diseases
MALINOW, M. R. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00854.x · Cited by 247
Mendelian disorders deserve more attention
Antonarakis, S. E., & Beckmann, J. S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1826 · Cited by 242
Regional variations in cardiovascular risk factors in India: India heart watch
Gupta, R. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i4.112 · Cited by 235
Genetics of coronary artery disease and myocardial infarction
Dai, X. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i1.1 · Cited by 224
Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies
Li, M., Hou, W., Zhang, X., Hu, L., & Tang, Z. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.051 · Cited by 222
WORTH, R. M., KATO, H., RHOADS, G. G., KAGAN, A., & SYME, S. L. (1975) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112186 · Cited by 220
Prevalence of coronary heart disease--United States, 2006-2010.
(2011) · PubMed · Cited by 215
Efficacy of Ranolazine in Patients With Chronic Angina
Wilson, S. R., Scirica, B. M., Braunwald, E., Murphy, S. A., Karwatowska-Prokopczuk, E., Buros, J. L., Chaitman, B. R., & Morrow, D. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.037 · Cited by 198 · cited 2×
“, 2009) and also decrease the death rate (Wilson et al., 2009).”
BackgroundMolecular genetics of coronary artery disease
Wang, Q. (2005) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000160373.77190.f1 · Cited by 196
Familial Patterns in Ischaemic Heart Disease
Rose, G. (1964) · Journal of Epidemiology & Community Health · doi:10.1136/jech.18.2.75 · Cited by 191
Coronary risk associated with age and sex of parental heart disease in the Framingham Study
Schildkraut, J. M., Myers, R. H., Cupples, L. A., Kiely, D. K., & Kannel, W. B. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90477-3 · Cited by 187
Ouguerram, K., Chetiveaux, M., Zair, Y., Costet, P., Abifadel, M., Varret, M., Boileau, C., Magot, T., & Krempf, M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000133684.77013.88 · Cited by 185
Koch, W., Kastrati, A., Böttiger, C., Mehilli, J., von Beckerath, N., & Schömig, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00467-1 · Cited by 182
Evidence for a Role of Phospholipid Oxidation Products in Atherogenesis
Berliner, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00098-6 · Cited by 182
Health Benefits of Smoking Cessation
Samet, J. M. (1991) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00816-9 · Cited by 177
Epidemiological study of coronary heart disease in urban population of Delhi.
Chadha, S. L., Radhakrishnan, S., Ramachandran, K., Kaul, U., & Gopinath, N. (1990) · PubMed · Cited by 176
Exacerbation of Atherosclerosis by Hypertension: Potential Mechanisms and Clinical Implications
Chobanian, A. V., & Alexander, R. D. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440160064009 · Cited by 176
Morrow, D. A., Scirica, B. M., Chaitman, B. R., McGuire, D. K., Murphy, S. A., Karwatowska-Prokopczuk, E., McCabe, C. H., & Braunwald, E. (2009) · Circulation · doi:10.1161/circulationaha.107.763912 · Cited by 170
Visceral Fat Accumulation and Cardiovascular Disease
Matsuzawa, Y., Nakamura, T., Shimomura, I., & Kotani, K. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00481.x · Cited by 169
Jonas, M., Reicher-Reiss, H., Boyko, V., Shotan, A., Mandelzweig, L., Goldbourt, U., & Behar, S. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00191-9 · Cited by 164
Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris
Rousseau, M. F., Pouleur, H., Cocco, G., & Wolff, A. A. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.025 · Cited by 160
The natural history of homocystinuria due to cystathionine β-synthase deficiency
Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B., Pyeritz, R. E., Andria, G., Boers, G. H. J., Bromberg, I. L., Cerone, R., et al. (1985) · Europe PMC (PubMed Central) · Cited by 159
Thomas, C. B., & Cohen, B. H. (1955) · Annals of Internal Medicine · doi:10.7326/0003-4819-42-1-90 · Cited by 157
Randomized placebo-controlled trial of amlodipine in vasospastic angina
Chahine, R. A., Feldman, R. L., Giles, T. D., NICOD, P. H., Raizner, A. E., Weiss, R., & Vanov, S. K. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90310-w · Cited by 156
THROMBOSIS OF THE CORONARY ARTERIES
HERRICK, J. B. (1919) · JAMA · doi:10.1001/jama.1919.02610060001001 · Cited by 152
Wagenknecht, L. E., D'Agostino, R. B., Haffner, S. M., Savage, P. J., & Rewers, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1812 · Cited by 149
Krishnan, M. N., Zachariah, G. A., Venugopal, K., Mohanan, P. P., Harikrishnan, S., Sanjay, G., Jeyaseelan, L., & Thankappan, K. R. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0189-3 · Cited by 149
You, S.-A., Archacki, S. R., Angheloiu, G. O., Moravec, C. S., Rao, S., Kinter, M. T., Topol, E. J., & Wang, Q. K. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00124.2002 · Cited by 147
Consensus Physical Activity Guidelines for Asian Indians
Misra, A., Nigam, P., Hills, A. P., Chadha, D. S., Sharma, V., Deepak, K. K., Vikram, N. K., Joshi, S., Chauhan, A. K., Khanna, K., et al. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0111 · Cited by 145
Lund‐Katz, S., Laplaud, P. M., Phillips, M. C., & Chapman, M. J. (1998) · Biochemistry · doi:10.1021/bi980828m · Cited by 143
NONOXIDATIVE MODIFICATIONS OF LIPOPROTEINS IN ATHEROGENESIS
Tabas, I. A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.123 · Cited by 138
Storhaug, H. M., Norvik, J. V., Toft, I., Eriksen, B. O., Løchen, M., Zykova, S. N., Solbu, M. D., White, S., Chadban, S. J., & Jenssen, T. G. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-115 · Cited by 137
Savonitto, S., Ardissino, D., Egstrup, K., Rasmussen, K., Bae, E. A., Omland, T. M., Schjelderup-Mathiesen, P. M., Marraccini, P., Wahlqvist, I., Merlini, P. A., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00489-0 · Cited by 132
Kalinina, N., Agrotis, A., Antropova, Y., Ilyinskaya, O. P., Smirnov, V. N., Tararak, E. M., & Bobik, A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000133605.89421.79 · Cited by 106
Diabetes, hyperlipidemia, and coronary artery disease
Haffner, S. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00213-1 · Cited by 94
Cardiovascular Disease Epidemiology: A Journey From the Past Into the Future
Epstein, F. H. (1996) · Circulation · doi:10.1161/01.cir.93.9.1755 · Cited by 94
Archacki, S. R., Angheloiu, G. O., Tian, X.-L., Tan, F. L., DiPaola, N., Shen, G.-Q., Moravec, C. S., Ellis, S. G., Topol, E. J., & Wang, Q. K. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00181.2002 · Cited by 93
Uric acid and cardiovascular disease risk reclassification: Findings from NHANES III
ZALAWADIYA, S. K., Veeranna, V., Mallikethi‐Reddy, S., Bavishi, C., Lunagaria, A., Kottam, A. R., & Afonso, L. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487313519346 · Cited by 89
Mechanisms of Disease: the genetic basis of coronary heart disease
Kullo, I. J., & Ding, K. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0982 · Cited by 87
Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort
Chuang, S., Chen, J., Yeh, W., Wu, C., & Pan, W. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.055 · Cited by 85
Genetics of Coronary Artery Disease
Lieb, W., & Vasan, R. S. (2013) · Circulation · doi:10.1161/circulationaha.113.005350 · Cited by 85
A survey of sub-Saharan gene flow into the Mediterranean at risk loci for coronary artery disease
Álvarez‐Álvarez, M. M., Zanetti, D., Carreras‐Torres, R., Moral, P., & Athanasiadis, G. I. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.200 · Cited by 85
Plaque progression and regression in atherothrombosis
Ibáñez, B., Vilahur, G., & Badimón, J. J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02483.x · Cited by 82
Lipids, glucose intolerance and vascular disease: the Framingham Study.
Pw, W., Kannel, W. B., & Anderson, K. M. (1985) · PubMed · Cited by 76
Extreme Evolutionary Disparities Seen in Positive Selection across Seven Complex Diseases
Corona, E., Dudley, J. T., & Butte, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012236 · Cited by 72
Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals
Skak-Nielsen, H., Torp-Pedersen, C. T., Finer, N., Caterson, I. D., Gaal, L. V., James, W. P. T., Maggioni, A. P., Sharma, A. M., Coutinho, W. F., & Andersson, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059121 · Cited by 68
Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women
Montalcini, T., Gorgone, G., Gazzaruso, C., Sesti, G., Perticone, F., & Pujia, A. (2007) · Internal and Emergency Medicine · doi:10.1007/s11739-007-0004-3 · Cited by 65
Lowering serum urate does not improve endothelial function in patients with type 2 diabetes
Waring, W. S., McKnight, J. A., Webb, D. J., & Maxwell, S. R. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0817-7 · Cited by 63
Uric Acid Reduction: A New Paradigm in the Management of Cardiovascular Risk?
Dawson, J., Quinn, T., & Walters, J. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058797 · Cited by 63
Advances in the genetic basis of coronary artery disease
Wang, Q. K. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0012-6 · Cited by 60
Fibroblast Growth Factor-1 Stimulates Branching and Survival of Myocardial Arteries
Carmeliet, P. (2000) · Circulation Research · doi:10.1161/01.res.87.3.176 · Cited by 58
Uric Acid Measurement Improves Prediction of Cardiovascular Mortality in Later Life
Dutta, A., Henley, W., Pilling, L. C., Wallace, R. B., & Melzer, D. R. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12149 · Cited by 57
Effect of 9p21.3 Coronary Artery Disease Locus Neighboring Genes on Atherosclerosis in Mice
Kim, J. B., deLuna, A., Mungrue, I. N., Vu, C., Pouldar, D., Civelek, M., Orozco, L. D., Wu, J., Wang, X., Charugundla, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.064881 · Cited by 57
Total Antioxidant Status at High Altitude in Lowlanders and Native Highlanders: Role of Uric Acid
Sinha, S., Singh, S. N., & Ray, U. S. (2009) · High Altitude Medicine & Biology · doi:10.1089/ham.2008.1082 · Cited by 55
Mika Kivimaki, B., Theorell, T., Westerlund, H., Vahtera, J., & Alfredsson, L. S. (2008) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2007.063578 · Cited by 55
Yamada, A., Ichihara, S., Murase, Y., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0556-x · Cited by 55
Antiplatelet treatment for coronary heart disease
Clappers, N., Brouwer, M. A., & Verheugt, F. W. A. (2005) · Heart · doi:10.1136/hrt.2005.071209 · Cited by 55
Girelli, D., Martinelli, N., Peyvandi, F., & Olivieri, O. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1242721 · Cited by 55
A “natural experiment” in cardiovascular epidemiology in the early 21st century: Figure 1
Sekikawa, A. M., Horiuchi, B. Y., Edmundowicz, D., Ueshima, H., Curb, J. D., Sutton-Tyrrell, K., Okamura, T., Kadowaki, T., Kashiwagi, A., Mitsunami, K., et al. (2003) · Heart · doi:10.1136/heart.89.3.255 · Cited by 53
Kadariya, Y., Yin, B., Tang, B., Shinton, S. A., Quinlivan, E. P., Xiang, H., Klein–Szanto, A. J., Al‐Saleem, T., Bassing, C. H., Hardy, R. R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0145 · Cited by 50
Changes in serum uric acid levels and cardiovascular events: A meta-analysis
Savarese, G., Ferri, C., Trimarco, B., Rosano, G. M. C., Dellegrottaglie, S., Losco, T., Casaretti, L., D’Amore, C., Gambardella, F., Prastaro, M., et al. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.03.001 · Cited by 50
Liu, P. Y., Zhang, Y. Y., Lü, Y., Long, J.-R., Shen, H., Zhao, L.-J., Xu, F., Xiao, P., Xiong, D. H., Liu, Y. J., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024752 · Cited by 48
Pilbrow, A. P., Folkersen, L., Pearson, J. F., Brown, C. M., McNoe, L. A., Wang, N. M., Sweet, W. E., Tang, W. H. W., Black, M. A., Troughton, R. W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039574 · Cited by 47
Zhu, X., Fejerman, L., Luke, A. H., Adeyemo, A., & Cooper, R. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi060 · Cited by 29
Association of chromosomal region 9p21.3 with Coronary Artery Disease – A local perspective
Bellary, K., Murthy, D. K., Vala, D. R., Hanumanth, S. R., & Quraishi, M. K. (2016) · Journal of Indian College of Cardiology · doi:10.1016/j.jicc.2016.12.002 · Cited by 5
Molecular Genetics of Coronary Artery Disease and Myocardial Infarction
Marı́n-Garcı́a, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00007-x · Cited by 4
Cited by
PCSK9: A Multi-Faceted Protein That Is Involved in Cardiovascular Biology
Sundararaman, S. S., Döring, Y., & van der Vorst, E. P. C. (2021) · Biomedicines · doi:10.3390/biomedicines9070793 · Cited by 67
Liu, C., Shi, F., Li, W., & Chen, J. (2022) · Medicina Oral Patología Oral y Cirugia Bucal · doi:10.4317/medoral.25514 · Cited by 11
Liu, J., Wang, X., Lin, J., Li, S., Deng, G., & Wei, J. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s329005 · Cited by 8
Metadata
- Authors
- Malakar, A. K., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2019-02-20
- Volume
- 234
- Issue
- 10
- Pages
- 16812-16823
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2917025828
- Cited by
- 1,141
- References
- 133
- FWCI
- 52.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.